How many insider declarations has Riley Jennifer filed?

Riley Jennifer has filed 4 public insider declarations with SEC (Form 4).

What is Riley Jennifer's role?

Riley Jennifer's reported role is not specified by the regulator across the filings.

Which companies does Riley Jennifer report trades for?

Riley Jennifer reports trades for Avalo Therapeutics, Inc..

What is Riley Jennifer's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 45k€.

← Executives ★ Sign in to follow

RJ

Riley Jennifer

OFFICER

·SEC (Form 4)

Avalo Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€45,027

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the complete record of transactions filed by Riley Jennifer. Officer active across 1 company, notably Avalo Therapeutics, Inc.. Cumulatively, 4 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €45k. Activity tracked since 10 December 2025. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Riley Jennifer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Avalo Therapeutics, Inc. (US)

申报4 总计

▼

Riley Jennifer

Chief Strategy Officer高管2026年8月11日Avalo Therapeutics, Inc.

US$52,0120SEC ↗

2,655 股@ US$19.5903Common StockSEC:0002047607-26-000008:0

●

Riley Jennifer

Chief Strategy Officer高管2026年6月10日Avalo Therapeutics, Inc.

18SEC ↗

588 股Common StockSEC:0002047607-26-000006:0

◆

Riley Jennifer

Chief Strategy Officer高管2026年5月21日Avalo Therapeutics, Inc.

0SEC ↗

34,200 股0Common StockSEC:0002047607-26-000004:0

●

Riley Jennifer

Chief Strategy Officer高管2025年12月10日Avalo Therapeutics, Inc.

US$2,61219SEC ↗

637 股@ US$4.10100.0% 占其流量Common StockSEC:0001470831-25-000411:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RJ

Riley Jennifer

OFFICER

·SEC (Form 4)

Avalo Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€45,027

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the complete record of transactions filed by Riley Jennifer. Officer active across 1 company, notably Avalo Therapeutics, Inc.. Cumulatively, 4 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €45k. Activity tracked since 10 December 2025. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.